Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Thyroid Neoplasms 1Thyroid Diseases 1Prostatic Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Lymphoma 1Lung Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

selpercatinib 3Sorafenib 3cabozantinib 2Thyroid (USP) 2Sodium 2Radiofrequency Ablation 2Metformin 2Data Collection 2vandetanib 1tomivosertib 1temsirolimus 1repotrectinib 1pralsetinib 1pembrolizumab 1lenvatinib 1binimetinib 1apatinib 1acetaminophen, codeine drug combination 1Watchful Waiting 1Vitamin B 12 1Tramadol 1Thyroxine 1Thyrotropin-Releasing Hormone 1Thyroidectomy 1Technetium Tc 99m Sestamibi 1Surgical Procedures, Operative 1Pemetrexed 1Panobinostat 1Observation 1Negative-Pressure Wound Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Diseases × Panobinostat × Head & Neck × Clear all
NCT01013597 2019-11-29

Trial of LBH589 in Metastatic Thyroid Cancer

University of Wisconsin, Madison

Phase 2 Completed
13 enrolled 11 charts
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡